Literature DB >> 15726252

Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.

Dirk Fischer1, Maggie C Walter, Kristina Kesper, Jens A Petersen, Stefania Aurino, Vincenzo Nigro, Christian Kubisch, Thomas Meindl, Hanns Lochmüller, Kai Wilhelm, Horst Urbach, Rolf Schröder.   

Abstract

Mutations in the fukutin-related protein (FKRP) have recently been demonstrated to cause limb girdle muscular dystrophy type 2I (LGMD2I), one of the most common forms of the autosomal recessive LGMDs in Europe. We performed a systematic clinical and muscle MRI assessment in 6 LGMD2I patients and compared these findings with those of 14 patients with genetically confirmed diagnosis of other forms of autosomal recessive LGMDs or dystrophinopathies. All LGMD2I patients had a characteristic clinical phenotype with predominant weakness of hip flexion and adduction, knee flexion and ankle dorsiflexion. These findings were also mirrored on MRI of the lower extremities which demonstrated marked signal changes in the adductor muscles, the posterior thigh and posterior calf muscles. This characteristic clinical and MRI phenotype was also seen in LGMD2A. However, in LGMD2A there was a selective involvement of the medial gastrocnemius and soleus muscle in the lower legs which was not seen in LGMD2I. The pattern in LGMD2A and LGMD2I were clearly different from the one seen in alpha-sarcoglycanopathy and dystrophinopathy type Becker which showed marked signal abnormalities in the anterior thigh muscles. Our results indicate that muscular MRI is a powerful tool for differentiating LGMD2I from other forms of autosomal recessive LGMDs and dystrophinopathies.

Entities:  

Mesh:

Year:  2005        PMID: 15726252     DOI: 10.1007/s00415-005-0684-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients.

Authors:  W H Linssen; N C Notermans; Y Van der Graaf; J H Wokke; P A Van Doorn; C J Höweler; H F Busch; A E De Jager; M De Visser
Journal:  Brain       Date:  1997-11       Impact factor: 13.501

2.  Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C.

Authors:  M Brockington; Y Yuva; P Prandini; S C Brown; S Torelli; M A Benson; R Herrmann; L V Anderson; R Bashir; J M Burgunder; S Fallet; N Romero; M Fardeau; V Straub; G Storey; C Pollitt; I Richard; C A Sewry; K Bushby; T Voit; D J Blake; F Muntoni
Journal:  Hum Mol Genet       Date:  2001-12-01       Impact factor: 6.150

3.  Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype.

Authors:  I Illa; C Serrano-Munuera; E Gallardo; A Lasa; R Rojas-García; J Palmer; P Gallano; M Baiget; C Matsuda; R H Brown
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

4.  Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).

Authors:  T Weiler; R Bashir; L V Anderson; K Davison; J A Moss; S Britton; E Nylen; S Keers; E Vafiadaki; C R Greenberg; C R Bushby; K Wrogemann
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

5.  Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy.

Authors:  B Eymard; N B Romero; F Leturcq; F Piccolo; A Carrié; M Jeanpierre; H Collin; N Deburgrave; K Azibi; M Chaouch; L Merlini; C Thémar-Noël; I Penisson; M Mayer; O Tanguy; K P Campbell; J C Kaplan; F M Tomé; M Fardeau
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

6.  Phenotypic spectrum associated with mutations in the fukutin-related protein gene.

Authors:  Eugenio Mercuri; Martin Brockington; Volker Straub; Susana Quijano-Roy; Yeliz Yuva; Ralf Herrmann; Susan C Brown; Silvia Torelli; Victor Dubowitz; Derek J Blake; Norma B Romero; Brigitte Estournet; Caroline A Sewry; Pascale Guicheney; Thomas Voit; Francesco Muntoni
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

Review 7.  Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.

Authors:  Carsten G Bönnemann; Richard S Finkel
Journal:  Semin Pediatr Neurol       Date:  2002-06       Impact factor: 1.636

8.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B.

Authors:  R Bashir; S Britton; T Strachan; S Keers; E Vafiadaki; M Lako; I Richard; S Marchand; N Bourg; Z Argov; M Sadeh; I Mahjneh; G Marconi; M R Passos-Bueno; E de S Moreira; M Zatz; J S Beckmann; K Bushby
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

9.  Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.

Authors:  Marina Fanin; Anna Chiara Nascimbeni; Luigi Fulizio; Carlo Pietro Trevisan; Marija Meznaric-Petrusa; Corrado Angelini
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  On symptomatic heterozygous alpha-sarcoglycan gene mutation carriers.

Authors:  Dirk Fischer; Stefania Aurino; Vincenzo Nigro; Rolf Schröder
Journal:  Ann Neurol       Date:  2003-11       Impact factor: 10.422

View more
  34 in total

1.  MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies.

Authors:  R Stramare; V Beltrame; R Dal Borgo; L Gallimberti; A C Frigo; E Pegoraro; C Angelini; L Rubaltelli; G P Feltrin
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

Review 2.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

3.  Morphologic imaging in muscular dystrophies and inflammatory myopathies.

Authors:  Adrian Degardin; David Morillon; Arnaud Lacour; Anne Cotten; Patrick Vermersch; Tanya Stojkovic
Journal:  Skeletal Radiol       Date:  2010-05-07       Impact factor: 2.199

4.  Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.

Authors:  Arne Fischmann; Monika Gloor; Susanne Fasler; Tanja Haas; Rachele Rodoni Wetzel; Oliver Bieri; Stephan Wetzel; Karl Heinimann; Klaus Scheffler; Dirk Fischer
Journal:  J Neurol       Date:  2011-02-22       Impact factor: 4.849

5.  Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].

Authors:  Chi-Hsien Wang; Yiumo Michael Chan; Ru-Hang Tang; Bin Xiao; Peijuan Lu; Elizabeth Keramaris-Vrantsis; Hui Zheng; Chunping Qiao; Jiangang Jiang; Juan Li; Hsin-I Ma; Qilong Lu; Xiao Xiao
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

7.  Muscle MRI in muscular dystrophies.

Authors:  Jordi Díaz-Manera; Jaume Llauger; Eduard Gallardo; Isabel Illa
Journal:  Acta Myol       Date:  2015-12

8.  Bioimpedance Analysis as a Method to Evaluate the Proportion of Fatty and Muscle Tissues in Progressive Myopathy in Pompe Disease.

Authors:  Agnieszka Różdżyńska-Świątkowska; Elżbieta Jurkiewicz; Anna Tylki-Szymańska
Journal:  JIMD Rep       Date:  2015-08-08

9.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

10.  Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.

Authors:  Cornelia Kornblum; Götz Lutterbey; Manuela Bogdanow; Kristina Kesper; Hans Schild; Rolf Schröder; Mike Peter Wattjes
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.